Using three serotypes (four strains) of cultivable porcine rotavirus as immunizing antigens, 10 neutralizing monoclonal antibodies were characterized. One VP4-specific monoclonal antibody directed against porcine rotavirus BEN-144 (serotype G4) neutralized human rotavirus strain ST-3 in addition to the homologous porcine virus. All nine VP7-specific monoclonal antibodies were highly specific for viruses of the same serotype as the immunizing rotavirus strain. One exception was the VP7-specific monoclonal antibody C3/1, which neutralized both serotype G3 and G5 rotaviruses. However, this monoclonal antibody did not neutralize the porcine rotavirus AT/76, also of serotype G3, nor mutants of SA-ll virus (serotype G3) which were selected with monoclonal antibody A10/N3 and are known to have mutations affecting the C antigenic region.
Rotavirus, an important causative agent of acute nonbacterial gastroenteritis, comprises at least 10 defined serotypes from humans and animals (4, 6, 13, 16, 17, 21, 23, 24) . Serotypes are defined on the basis of a 20-fold difference in reciprocal antibody neutralization titers (3, 16) . Two viral proteins, VP4 (the fourth gene product) and VP7 (the seventh, eighth, or ninth gene product), present on the outer capsid of rotavirus elicit neutralizing antibodies (1) . The product of segment 4 was previously called VP3 but was renamed VP4 when the protein encoded by genome segment 3 was identified as a structural protein (19) . The observations that virus strains with different combinations of serotype specificities exist in nature and also that the neutralization specificities on the outer capsid proteins VP4 and VP7 segregate independently upon gene reassortment have led to a new system of rotavirus classification which requires that all isolates be defined in terms of both of their surface proteins, VP4 and VP7 (14) (15) (16) . This binary system of classification, which is similar to that used for influenza A viruses, was discussed at the VIIth International Congress of Virology, 1987, Edmonton, Canada. The original serotype numbering has been agreed on and adopted as the G (for glycoprotein) serotype specificities (2) . However, a numbering system for the P (for protease-sensitive protein, i.e., VP4) serotype specificities has not yet been determined.
Studies in Australia, the United States, Europe, and Mexico have identified at least four serotypes of porcine rotavirus (4, 21, 23, 24) . The OSU and Gottfried strains belong to serotypes G5 and G4, respectively (4, 16) . A third porcine rotavirus serotype which we have reported (21) is antigenically similar to human rotavirus RV-3 (serotype G3). A very recent study in Mexico has described the occurrence of a new rotavirus serotype in diarrheic piglets which is not related to previously reported serotypes GI to G6 (24) . Various monoclonal antibodies (MAbs) have been developed against human and animal rotaviruses (9, 11. 12, 18, 25-27) . Although two neutralizing MAbs against porcine rotavirus (OSU and Gottfried strains) have been produced (20, 25) , both react with more than one serotype and no reports have been published describing the production and characterization of serotype-specific neutralizing MAbs against porcine rotavirus. Hence, derivation of neutralizing MAbs Corresponding author. against different serotypes of porcine rotaviruses may provide useful reagents for serotyping of porcine rotaviruses in an enzyme immunoassay.
All viruses used in this study except porcine BEN-144 were propagated in the presence of porcine trypsin (0.5 pg/ml, Sigma Chemical Co., St. Louis, Mo.) as described previously (21) . Porcine rotavirus BEN-144, which originated from a fecal sample from a diarrheic piglet, was adapted to growth in cell culture. Attempts to isolate this virus directly from the feces into MA-104 cells were not successful, but the virus could be isolated by using primary monkey kidney cells (Commonwealth Serum Laboratories, Victoria, Australia). BEN-144 virus was subsequently adapted to the MA-104 cell line. Pancreatin from porcine pancreas (grade VI, 4x U.S.P.; Sigma) was used at 100 p.g/ml to activate this virus rather than trypsin and was incorporated in the maintenance medium at 30 ptg/ml. Hyperimmune serum to BEN-144 virus produced in BALB/c mice by the method of Offit and Blavat (22) and antisera raised in rabbits (21) to CRW-8, TFR-41, and ST-3 viruses were used in fluorescent focus neutralization (FFN) tests (21) to identify the serotype specificity of virus isolate (Table 1) . Clearly, BEN-144 was serotypically distinct from the porcine rotaviruses previously isolated in Australia, serotypes G3 and G5 (21 
Porcine (MDR-13) G3 <200 8 x 105 5 x 104 2 x 10i 5 x 104 <200 <200 <200 <200 <200
Porcine (AT/76) G3 2 x 10i <200 <200 <200 <200 <200 <200 <200 <200 <200
Porcine (BEN-144) G4 <200 200 <200 <200 <200 <200 <200 Simian (SA-11) G3 <200 3.2 x 106 <200 <200 <200 <200 <200 <200 <200 <200
Simian (RRV) G3 <200 2 x 105 <200 <200 <200 <200 <200 <200 <200 <200
Canine (K9) G3 <200 8 X 105 <200 <200 <200 <200 <200 <200 <200 <200
"The MAbs were all in the form of ascites. Also see footnote a, the United States with the Gottfried strain of porcine rotavirus (16) . Neutralizing MAbs were produced against Australian porcine CRW-8, MDR-13, BEN-144, and TFR-41 rotavirus strains by the method previously described for human rotavirus MAbs by Coulson et al. (7) . Two MAbs were produced against porcine CRW-8 (63), three against MDR-13 (63), three against BEN-144 (G4), and two against TFR-41 (G5) rotavirus (Table 2 ). In FFN tests (Table 2) , MAb Cl/1 reacted with porcine rotaviruses CRW-8 and AT/76 only, while MAb C3/1, also derived against porcine rotavirus CRW-8, was more broadly cross-reactive with porcine rotaviruses MDR-13 (63), TFR-41 (G5), and a group of serotype G3 rotaviruses (RV-3, RRV, SA-11, and K9). This MAb (C3/1) did not neutralize virus strains from serotype G1, G2, or G6 (data not shown) or G4 virus strains ( Table 3 ). The MAbs derived against the porcine MDR-13 strain neutralized only the parental strain and not the other mammalian rotaviruses tested. The MAbs raised against the porcine TFR-41 virus reacted with the viruses of the same serotype as the immunizing antigen. Three neutralizing MAbs were produced against porcine rotavirus BEN-144 (G4). MAbs B2/4 and B3/1 neutralized the parental strain (the immunizing antigen) only and not other members of serotype G4. MAb B1/3 gave high titers with BEN-144 and low titers (3, 200) with human rotavirus ST-3 and did not neutralize VA70 (all serotype G4).
Most of the previously described VP7-specific MAbs frequently failed to immunoprecipitate VP7 or to react with rotaviral proteins in Western blots (immunoblots) (7) . Therefore, we derived reassortants to characterize our neutralizing MAbs. Reassortant rotaviruses were produced under selective pressure of specific MAbs by the method of Hoshino et al. (14) . These genetic reassortants include strains CO-UK (CRW8 x UK), RV5-CO (RV5 x CRW8), TR-SA (TFR41 x SA-11), RV5-TR (RV5 x TFR41), MD-UK (MDR13 x UK), and BN-UK (BEN144 x UK). The viral RNA patterns of these reassortants as well as those of the parental strains were determined by polyacrylamide gel electrophoresis as described previously (21, 22) , and the results are shown in Fig. 1 and Table 3 . The identity of the outer capsid polypeptides of the reassortants was confirmed by neutralization tests with MAbs of known specificity ( Table 4 ). The reassortants RV5-CO and RV5-TR (which have derived segment 4 from CRW-8 and TFR-41, respectively) were neutralized by a VP7-specific MAb (RV5:4) but not by MAb RV5:2 directed against VP4 of RV-5, indicating that these reassortants have VP7 of RV-5 and VP4 from the other parent. Similarly, the origin of VP4 and VP7 polypep- RNA segments are numbered 1 to 11 based on migration from top to bottom as determined by polyacrylamide gel electrophoresis. The RNAs of the reassortant viruses were coelectrophoresed with RNAs from both of their respective parent viruLs strains (22) . " Genes of these reassortants could not be assigned to parental genes under the experimentall conditions described.
J. VIROL. Tables 3 and 4 for details on reassortants.
Lanes A, B, and C were from a separate gel.
tides in the reassortants CO-UK, MD-UK, BN-UK, and TR-SA was established.
The specificity of MAbs generated in this study was determined by their ability to neutralize the reassortants ( (18) (Table 5). MAb C3/1 directed against VP7 of CRW-8 neutralized wild-type SA-11 rotavirus and the mutants VA1l/M9 and VB8/Xl. Mutant VA10/N3, however, was highly resistant to C3/1. Anti-SA-11 MAb All/M9 neutralized four strains of porcine rotavirus (CRW-8, MDR-13, AT/76, and TFR-41), and B8/Xl reacted with porcine strains CRW-8 and AT/76. The reactivity of anti-SA-11 MAbs with CRW-8 and AT/76 supports the classification of these porcine viruses into serotype G3 (21) . All porcine rotaviruses were resistant to MAb AlO/N3 (anti-SA-11). Similarly, SA-11 rotaviruses, both wild type and mutants, were resistant to MAb Cl/i (anti-CRW-8).
In some cases, the titers of MAbs appeared to change when the VP7 antigens against which they reacted were associated with different VP4 antigens. For example, MAbs Cl/i and B8/X1 gave 8 x 105 and 2 x 105 neutralization antibody titers, respectively, with porcine CRW-8 virus, but both MAbs had a much higher antibody titer (3. Antigenic mutants of SA-11 virus are prefixed with the letter V followed by the MAb(s) used to select them (18) . * See footnote a, Table 2 .
VP7-specific MAbs against porcine rotavirus CRW-8.
"VP7-specific MAbs against simian rotavirus SA-11 (26) . Titers of these MAbs against SA-11 mutants were reconfirmed in the present study.
" NT, Not tested.
VP7 from porcine CRW-8 rotavirus and VP4 from bovine UK rotavirus. Conversely, the same reassortant CO-UK reacted at a low neutralizing antibody titer (3, 200) with another MAb, All/M9, while its parent CRW-8 was neutralized by the same MAb (All/M9) at a higher antibody titer (50,000). The nine VP7-specific MAbs did not neutralize rotaviruses belonging to serotypes Gi, G2, G6, and G8 (data not shown). All but one of these MAbs reacted with viruses only of the same serotype as the immunizing strain. One MAb, C3/1, directed against VP7 of porcine strain CRW-8 (G3) neutralized porcine strain and most serotype G3 rotaviruses tested, including human rotavirus strain This suggests that C3/1 recognizes an antigenic site on the outer shell glycoproteins common to particular rotaviruses of serotypes G3 and G5. This MAb failed to neutralize mutants of SA-11 virus selected with MAb A10/N3 that are known to have mutations affecting the C region of VP7 (5). Coulson et al. (8) from their studies with MAbs reported a similar phenomenon in which antigenicity is shared between human serotypes G1 and G3 through an epitope on the major outer capsid protein (VP7) and suggested that epitopes on VP7 common to two different serotypes are responsible for the one-way neutralization crosses with polyclonal antisera noted in conventional serotyping (16, 21) .
In contrast to MAb C3/1, MAb Cl/i, also directed against VP7 of the CRW-8 strain of porcine rotavirus, was highly specific for the parent virus and porcine rotavirus AT/76 (63). Failure of MAb Cl/i to react with porcine MDR-13 and also the inability of anti-MDR-13 VP7-specific MAbs to react with other porcine rotaviruses belonging to the same serotype need to be explained. It 
